23.20
+0.80
+(3.57%)
At close: January 31 at 9:34:14 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| HATA YUJIRO S. Chief Executive Officer | Conversion of Exercise of derivative security | May 16, 2024 | 677,887 |
| RUIZ BRISENO ANDRES Officer | Sale | Feb 9, 2024 | 24,531 |
| STONE PAUL A Chief Financial Officer | Sale | Aug 29, 2023 | 9,303 |
| THRONE JASON Officer | Conversion of Exercise of derivative security | Jun 27, 2024 | 63,484 |
| WHITE MICHAEL ANTHONY Officer | Conversion of Exercise of derivative security | May 29, 2024 | 0 |
Related Tickers
SER Serina Therapeutics, Inc.
4.7000
+2.17%
AADI Aadi Bioscience, Inc.
2.8800
0.00%
CELC Celcuity Inc.
11.95
+1.96%
THTX Theratechnologies Inc.
1.4400
+0.70%
APGE Apogee Therapeutics, Inc.
41.36
-2.68%
VRDN Viridian Therapeutics, Inc.
19.38
-3.49%
ADCT ADC Therapeutics SA
1.6800
-2.33%
CRNX Crinetics Pharmaceuticals, Inc.
40.30
+0.10%
OVID Ovid Therapeutics Inc.
0.6634
-5.24%
COGT Cogent Biosciences, Inc.
9.31
-3.22%